Skip to main content
Log in

Laser- und Lichttherapie zur Behandlung der Strahlendermatitis

Laser and light therapy for treatment of radiation dermatitis

  • Leitthema
  • Published:
Der Hautarzt Aims and scope Submit manuscript

Zusammenfassung

Strahlendermatitis (SD) ist eine entzündliche Hauterkrankung, die als ungewollte Nebenwirkung der medizinischen Strahlentherapie (ST) auftreten kann, am häufigsten bei Patienten, die im Rahmen einer Krebserkrankung der HNO- bzw. Anal- und Vulvaregion behandelt werden. Die Nebenwirkungen an der Haut und Schleimhaut treten innerhalb von wenigen Wochen nach der Einleitung von ST auf, späte Nebenwirkungen können sich Monate bis Jahre nach der ST entwickeln. Therapeutisch kommen verschiedene Behandlungsansätze in Betracht wie Pentoxifillin, hyperbare Sauerstofftherapie, Lasertherapie und Photobiomodulationstherapie (PBMT). Um die verminderte Lebensqualität von Patienten mit ST-induzierter Fibrose zu begrenzen, ist eine unterstützende Pflege aus Schmerztherapie, psychologischer Unterstützung und Wundversorgung notwendig.

Abstract

Radiation dermatitis (RD), an inflammatory skin disease that can be an unwanted side effect of medical radiation therapy (RT), most commonly occurs in patients undergoing cancer of the ENT, anal, and vulvar regions. The side effects on the skin and mucous membranes occur within a few weeks after the initiation of RT; however, late side effects can develop months to years after the RT. Therapeutically, various treatment approaches are considered such as pentoxifylline, hyperbaric oxygen therapy, laser therapy, and PBMT. In order to limit the reduced quality of life of patients with RT-induced fibrosis, supportive care consisting of pain therapy, psychological support, and wound care is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Cancer Research UK (2012) Worldwide cancer statistics. http://www.cancerresearchuk.org/health-professional/cancer-statistics/worldwide-cancer. Zugegriffen: 25. Sept. 2017

    Google Scholar 

  2. The World Cancer Report—the major findings. Cent Eur J Public Health, 2003. 11(3):177–9

  3. Balagamwala EH, Stockham A, Macklis R, Singh AD (2013) Introduction to radiotherapy and standard teletherapy techniques. Dev Ophthalmol 52:1–14

    Article  PubMed  Google Scholar 

  4. Cox J, Ang K (2010) Radiation oncology: rationale, technique, results, 9. Aufl. Elsevier Mosby, Amsterdam, Maryland Heights

    Google Scholar 

  5. Ryan JL (2012) Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 132(3 Pt 2):985–993

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Singh M, Alavi A, Wong R, Akita Radiodermatitis S (2016) A review of our current understanding. Am J Clin Dermatol 17(3):277–292

    Article  PubMed  Google Scholar 

  7. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31(5):1341–1346

    Article  CAS  PubMed  Google Scholar 

  8. Fishbourne E, Ludi AB, Wilsden G et al (2017) Efficacy of a high potency O1 Manisa foot-and-mouth disease vaccine in cattle against heterologous challenge with a field virus from the O/ME-SA/Ind-2001 lineage collected in North Africa. Vaccine 35(20):2761–2765

    Article  CAS  PubMed  Google Scholar 

  9. Chen AP, Setser A, Anadkat MJ et al (2012) Grading dermatologic adverse events of cancer treatments: the common terminology criteria for adverse events version 4.0. J Am Acad Dermatol 67(5):1025–1039

    Article  PubMed  Google Scholar 

  10. Berthelet E, Truong PT, Musso K et al (2004) Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy. Am J Clin Oncol 27(6):626–631

    Article  PubMed  Google Scholar 

  11. Schnur JB, Graff Zivin J, Mattson DM Jr. et al (2012) Acute skin toxicity-related, out-of-pocket expenses in patients with breast cancer treated with external beam radiotherapy: a descriptive, exploratory study. Support Care Cancer 20(12):3105–3113

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hymes SR, Strom EA, Fife C (2006) Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 54(1):28–46

    Article  PubMed  Google Scholar 

  13. Spalek M (2016) Chronic radiation-induced dermatitis: challenges and solutions. Clin Cosmet Investig Dermatol 9:473–482

    Article  PubMed  PubMed Central  Google Scholar 

  14. Harper JL, Franklin LE, Jenrette JM, Aguero EG (2004) Skin toxicity during breast irradiation: pathophysiology and management. South Med J 97(10):989–993

    Article  PubMed  Google Scholar 

  15. Yarnold J, Brotons MC (2010) Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol 97(1):149–161

    Article  CAS  PubMed  Google Scholar 

  16. Wells M, MacBride S (2003) Radiation skin reactions. Elsevier, Amsterdam

    Google Scholar 

  17. Mendelsohn FA, Divino CM, Reis ED, Kerstein MD (2002) Wound care after radiation therapy. Adv Skin Wound Care 15(5):216–224

    Article  PubMed  Google Scholar 

  18. Muller K, Meineke V (2007) Radiation-induced alterations in cytokine production by skin cells. Exp Hematol 35(4 Suppl 1):96–104

    Article  PubMed  Google Scholar 

  19. Denham JW, Hauer-Jensen M (2002) The radiotherapeutic injury—a complex ‘wound’. Radiother Oncol 63(2):129–145

    Article  PubMed  Google Scholar 

  20. Wong RK, Bensadoun RJ, Boers-Doets CB et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21(10):2933–2948

    Article  PubMed  Google Scholar 

  21. Lanigan SW, Joannides T (2003) Pulsed dye laser treatment of telangiectasia after radiotherapy for carcinoma of the breast. Br J Dermatol 148(1):77–79

    Article  CAS  PubMed  Google Scholar 

  22. Nymann P, Hedelund L, Haedersdal M (2009) Intense pulsed light vs. long-pulsed dye laser treatment of telangiectasia after radiotherapy for breast cancer: a randomized split-lesion trial of two different treatments. Br J Dermatol 160(6):1237–1241

    Article  CAS  PubMed  Google Scholar 

  23. Bourgeois JF, Gourgou S, Kramar A, Lagarde JM, Guillot B (2008) A randomized, prospective study using the LPG technique in treating radiation-induced skin fibrosis: clinical and profilometric analysis. Skin Res Technol 14(1):71–76

    CAS  PubMed  Google Scholar 

  24. Jacobson G, Bhatia S, Smith BJ, Button AM, Bodeker K, Buatti J (2013) Randomized trial of pentoxifylline and vitamin E vs standard follow-up after breast irradiation to prevent breast fibrosis, evaluated by tissue compliance meter. Int J Radiat Oncol Biol Phys 85(3):604–608

    Article  CAS  PubMed  Google Scholar 

  25. Delanian S, Porcher R, Balla-Mekias S, Lefaix JL (2003) Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21(13):2545–2550

    Article  CAS  PubMed  Google Scholar 

  26. Delanian S, Porcher R, Rudant J, Lefaix JL (2005) Kinetics of response to long-term treatment combining pentoxifylline and tocopherol in patients with superficial radiation-induced fibrosis. J Clin Oncol 23(34):8570–8579

    Article  PubMed  Google Scholar 

  27. Magnusson M, Hoglund P, Johansson K et al (2009) Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5). Eur J Cancer 45(14):2488–2495

    Article  CAS  PubMed  Google Scholar 

  28. Gothard L, Cornes P, Earl J et al (2004) Double-blind placebo-controlled randomised trial of vitamin E and pentoxifylline in patients with chronic arm lymphoedema and fibrosis after surgery and radiotherapy for breast cancer. Radiother Oncol 73(2):133–139

    Article  CAS  PubMed  Google Scholar 

  29. Deree J, Martins JO, Melbostad H, Loomis WH, Coimbra R (2008) Insights into the regulation of TNF-alpha production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition. Clinics (Sao Paulo) 63(3):321–328

    Article  Google Scholar 

  30. Samlaska CP, Winfield EA (1994) Pentoxifylline. J Am Acad Dermatol 30(4):603–621

    Article  CAS  PubMed  Google Scholar 

  31. Marques LJ, Zheng L, Poulakis N, Guzman J, Costabel U (1999) Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. Am J Respir Crit Care Med 159(2):508–511

    Article  CAS  PubMed  Google Scholar 

  32. Patel V, McGurk M (2017) Use of pentoxifylline and tocopherol in radiation-induced fibrosis and fibroatrophy. Br J Oral Maxillofac Surg 55(3):235–241

    Article  CAS  PubMed  Google Scholar 

  33. Pritchard J, Anand P, Broome J et al (2001) Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy. Radiother Oncol 58(3):279–286

    Article  CAS  PubMed  Google Scholar 

  34. Gothard L, Stanton A, MacLaren J et al (2004) Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer. Radiother Oncol 70(3):217–224

    Article  CAS  PubMed  Google Scholar 

  35. Teas J, Cunningham JE, Cone L et al (2004) Can hyperbaric oxygen therapy reduce breast cancer treatment-related lymphedema? A pilot study. J Womens Health (Larchmt) 13(9):1008–1018

    Article  Google Scholar 

  36. Tran TN, Hoang MV, Phan QA et al (2015) Fractional epidermal grafting in combination with laser therapy as a novel approach in treating radiation dermatitis. Semin Cutan Med Surg 34(1):42–47

    Article  PubMed  Google Scholar 

  37. Veness M, Richards S (2012) Radiotherapy. In: Bolognia J, Jorizzo J, Schaffer J (Hrsg) Dermatology. Elsevier, New York

    Google Scholar 

  38. Schindl A, Schindl M, Schindl L, Jurecka W, Honigsmann H, Breier F (1999) Increased dermal angiogenesis after low-intensity laser therapy for a chronic radiation ulcer determined by a video measuring system. J Am Acad Dermatol 40(3):481–484

    Article  CAS  PubMed  Google Scholar 

  39. Schindl M, Kerschan K, Schindl A, Schon H, Heinzl H, Schindl L (1999) Induction of complete wound healing in recalcitrant ulcers by low-intensity laser irradiation depends on ulcer cause and size. Photodermatol Photoimmunol Photomed 15(1):18–21

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H.-J. Laubach.

Ethics declarations

Interessenkonflikt

H.-J. Laubach und J. Robijns geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Laubach, HJ., Robijns, J. Laser- und Lichttherapie zur Behandlung der Strahlendermatitis. Hautarzt 69, 5–9 (2018). https://doi.org/10.1007/s00105-017-4091-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00105-017-4091-4

Schlüsselwörter

Keywords

Navigation